InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.720
-0.050 (-2.82%)
At close: Aug 6, 2026, 4:00 PM EDT
1.704
-0.016 (-0.91%)
After-hours: Aug 6, 2026, 7:42 PM EDT
InflaRx Employees
InflaRx had 65 employees as of December 31, 2025. The number of employees decreased by 9 or -12.16% compared to the previous year.
Employees
65
Change (1Y)
-9
Growth (1Y)
-12.16%
Revenue / Employee
n/a
Profits / Employee
-$688,021
Market Cap
253.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -9 | -12.16% |
| Dec 31, 2024 | 74 | 12 | 18.97% |
| Dec 31, 2023 | 62 | 18 | 40.41% |
| Dec 31, 2022 | 44 | -12 | -20.75% |
| Dec 31, 2021 | 56 | 9 | 18.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Bicycle Therapeutics | 288 |
| ProQR Therapeutics | 187 |
| Entrada Therapeutics | 152 |
| Adagene | 128 |
| Orchestra BioMed Holdings | 86 |
| Cartesian Therapeutics | 75 |
| Surrozen | 44 |
IFRX News
- 14 hours ago - InflaRx Earnings release: Q2 2026 - Filings
- 14 hours ago - InflaRx files $250M mixed securities shelf - TheFly
- 15 hours ago - InflaRx Registration statement: Registration filing - Filings
- 16 hours ago - InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones - GlobeNewsWire
- 7 days ago - InflaRx to Report Second Quarter 2026 Results on August 6, 2026 - GlobeNewsWire
- 5 weeks ago - InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos - GlobeNewsWire
- 3 months ago - InflaRx upgraded to Strong Buy from Outperform at Raymond James - TheFly
- 3 months ago - InflaRx price target raised to $8 from $6 at H.C. Wainwright - TheFly